http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9737587-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8e7f99fe33de881c33a9c85e56177bd |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-185 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-18 |
filingDate | 2015-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9eb429eec39e7e94918a673b9133e7a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa528b9b31196c44a1d472bb5d8768fd |
publicationDate | 2017-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-9737587-B2 |
titleOfInvention | Treatment of autism spectrum disorders with ciliary neurotrophic factor peptide mimetic |
abstract | A method of treating autism spectrum disorders using a therapeutic amount of a synthetic amino acid sequence corresponding to a portion of human ciliary neurotrophic factor (CNTF). In particular, the synthetic amino acid sequence is VGDGGLFEKKL (SEQ ID NO: 1), referred to as Peptide 6. Peptide 6 was tested and shown to exert a neuroprotective effect by modulating CNTF/JAK/STAT pathway and LIF signaling and enhancing brain derived neurotrophic factor (BDNF) expression. |
priorityDate | 2014-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 357.